This inventor holds 2 USPTO granted patents. Top assignees: Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis, Biontech US Inc.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: The Innovative Mind of Joost Huibert Van Den Berg
Introduction: Joost Huibert Van Den Berg is a notable inventor based in Amsterdam, NL. He has made significant contributions to the field of immunotherapy, particularly through his research and innovations in T cell manufacturing. With his dedication to advancing cancer treatment, he holds a patent that showcases his expertise and vision.
Latest Patents: Joost's patent, titled "T cell manufacturing compositions and methods," focuses on the generation of antigen-specific T cells through controlled ex vivo induction or expansion. This method presents a promising avenue for highly specific and beneficial T cell therapies aimed at treating cancer and various other conditions. The patent emphasizes therapeutic T cell compositions that can fundamentally change how personalized antigen-specific T cell therapy is conducted.
Career Highlights: Throughout his career, Joost has contributed to important research initiatives in various institutions. He has worked at BioNTech US Inc., a company recognized for its groundbreaking work in immunotherapy, and Stichting Het Nederlands Kanker Instituut—Antoni van Leeuwenhoek Ziekenhuis, where he focused on cancer research and treatment.
Collaborations: Joost has collaborated with several talented individuals in his field, including Marit M Van Buuren and Divya Reddy Lenkala. Their joint efforts have further advanced the understanding and application of T cell therapies.
Conclusion: Joost Huibert Van Den Berg's contributions to the field of T cell manufacturing highlight his innovative spirit and dedication to improving cancer treatments. His patent serves as a testament to his capability as an inventor and his commitment to helping patients through advancements in T cell therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile